Treventis is a biotechnology company focused on therapeutics and diagnostics for protein misfolding diseases. The company has leveraged a drug design platform to synthesize a class of organic drug-like molecules with the capability of binding to both...Show all
Company (Alive / Active)
Phone: 416-603-5800 x 2975
60 Leonard Ave 4KD472
Toronto, M5T 0S8
Ontario, Canada
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Name | Firm |
---|---|
Login to see details | Robin Hood Ventures |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Anti-amyloid compounds containing benzofurazan | Feb 27, 2015 | Apr 10, 2018 | Patent |
Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine | Aug 28, 2009 | Apr 16, 2013 | Patent |
Compounds and methods for treating protein folding disorders | Nov 19, 2007 | Jan 29, 2013 | Patent |
Methods for identifying inhibitors of amyloid protein aggregation | Oct 26, 2018 | Application | |
Methods for identifying inhibitors of amyloid protein aggregation | May 16, 2016 | Application |